US OptionsDetailed Quotes
TGTX250502P49500
- 0.00
- 0.000.00%
15min DelayClose Apr 30 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest49.50Strike Price0.00Turnover95.11%IV-8.77%PremiumMay 2, 2025Expiry Date3.99Intrinsic Value100Multiplier1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9082Delta0.0591Gamma11.10Leverage Ratio-0.1057Theta-0.0016Rho-10.08Eff Leverage0.0049Vega
TG Therapeutics Stock Discussion
Game-Changing MS Treatment? BRIUMVI Single-Dose Trial Reveals Breakthrough Potential
Game-Changing MS Treatment: BRIUMVI Reveals Exceptional Real-World Safety Profile
Medical Journals Reveal Breakthrough: BRIUMVI Succeeds Where Other MS Treatments Fall Short
How TG Therapeutics Transformed from Clinical-Stage to Profitable Biotech with 250% Revenue Growth
Can BRIUMVI Succeed Where Other MS Treatments Failed? New Clinical Data Reveals Promising Results
Larger Image: tradingview.com...
$TG Therapeutics (TGTX.US)$
No comment yet